Lynn Ware Driver, MD
Obstetrics & Gynecology · Nashville
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Driver’s office at (615) 329-6745 to ask if they take your plan before you enroll.
State licence records
1 licence
- Tennessee 19648Medical Doctor · since 1989 · expires 2024-07-31Specialty on the licence: Gynecology; Obstetrics and GynecologyExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- Univ of Tn · MDMemphis, TN · 1986Medical school
Residency and fellowship
- Ob/GynMemphis, TN · 1988–1990
- Ob/GynMemphis, TN · 1986–1988
Original Medicare doctor bills
$335
Medicare paid this office $335 for 11 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 11 | $318 | $29 |
Who their Medicare patients are
11 Original Medicare patients in 2024. Average age 70 · Under 65 0% · 85 and older 0% · Women 100% · Also on Medicaid 0% · Health risk score 0.41. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
The office billed $3,038, Medicare allowed $1,076 and paid $335; for 12 services of 2 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 11 | 12 | 70 | 0.41 | $3,038 | $335 |
| 2023 | 22 | 29 | 69 | 0.48 | $6,952 | $1,685 |
| 2022 | 24 | 41 | 68 | 0.51 | $16,789 | $3,456 |
| 2021 | 12 | 19 | 72 | 0.58 | $4,358 | $945 |
| 2020 | 14 | 24 | 68 | 0.55 | $4,840 | $939 |
| 2019 | 18 | 30 | 69 | 0.51 | $7,534 | $1,380 |
| 2018 | 18 | 27 | 70 | 0.89 | $8,858 | $1,332 |
| 2017 | 17 | 23 | 70 | 0.65 | $4,355 | $760 |
| 2016 | 15 | 19 | 70 | 0.74 | $4,482 | $745 |
| 2015 | 14 | 19 | 67 | 0.66 | $2,596 | $739 |
| 2014 | 22 | 36 | 65 | 0.68 | $10,055 | $3,718 |
| 2013 | 22 | 37 | 71 | 0.88 | $2,355 | $1,665 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Short return visit (20+ min) | 21 | $1,260 | $57 |
2022: 1 service
| Short return visit (20+ min) | 23 | $1,372 | $55 |
2020: 1 service
| Short return visit (20+ min) | 13 | $579 | $41 |
2019: 1 service
| Short return visit (20+ min) | 11 | $441 | $37 |
2018: 1 service
| Short return visit (20+ min) | 18 | $844 | $42 |
2017: 1 service
| Short return visit (20+ min) | 15 | $638 | $34 |
2016: 1 service
| Short return visit (20+ min) | 14 | $601 | $38 |
2014: 1 service
| Short return visit (20+ min) | 11 | $642 | $43 |
2013: 1 service
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 14 | $583 | $42 |
Medicaid work
$1,907 in 2023
Medicaid paid $1,907 for 66 billed services this clinician did in 2023, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 29 | $1,005 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 13 | $902 |
| Prenatal flow sheet documented in medical record by first prenatal visit (documentation includes at minimum blood pressure, weight, urine protein, uterine size, fetal heart tones, and estimated date of delivery). Report also: date of visit and, in a separate field, the date of the last menstrual period [LMP] (Note: If reporting 0501F Prenatal flow sheet, it is not necessary to report 0500F Initial prenatal care visit) (Prenatal) | 12 | $0 |
| Subsequent prenatal care visit (Prenatal) [Excludes: patients who are seen for a condition unrelated to pregnancy or prenatal care (eg, an upper respiratory infection; patients seen for consultation only, not for continuing care)] | 12 | $0 |
| 2023 | 66 | 4 | 14 | $1,907 |
| 2022 | 276 | 7 | 22 | $7,974 |
| 2021 | 36 | 2 | 15 | $1,119 |
| 2020 | 61 | 3 | 13 | $2,386 |
| 2018 | 15 | 1 | 13 | $27 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 77 | $2,751 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 71 | $1,803 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 34 | $968 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 13 | $878 |
| Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (< 14 weeks 0 days), transabdominal approach; single or first gestation | 18 | $630 |
| Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 16 | $495 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 47 | $449 |
2021
| Short return visit (20+ min) | 15 | $625 |
| Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 21 | $494 |
2020
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 14 | $1,009 |
| Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a previous scan), transabdominal approach, per fetus | 33 | $893 |
| Short return visit (20+ min) | 14 | $483 |
2018
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 15 | $27 |
Drugs they prescribed that Part D paid
$6,377
Pharmacies billed $6,377 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 74) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
65 generic and fewer than 11 brand-name prescriptions · $6,377 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 29 | $1,395 | $48 |
| Estradiol-Norethindrone Acetat | 11 | $306 | $28 |
| Oxybutynin Chloride | 12 | $78 | $7 |
Year by year
| 2024 | 74 | 13 | 0% (0) | None | $6,377 |
| 2023 | 78 | 17 | 0% (0) | None | $6,918 |
| 2022 | 40 | 16 | None | None | $4,041 |
| 2021 | 33 | None | 0% (0) | None | $3,162 |
| 2020 | 63 | 14 | 0% (0) | 37% | $4,811 |
| 2019 | 144 | 27 | 0% (0) | None | $5,891 |
| 2018 | 88 | 24 | None | 34% | $5,140 |
| 2017 | 72 | 18 | None | None | $5,550 |
| 2016 | 60 | 13 | 0% (0) | 45% | $7,407 |
| 2015 | 89 | 16 | 0% (0) | None | $12,633 |
| 2014 | 125 | 24 | None | 42% | $13,077 |
| 2013 | 106 | 19 | 0% (0) | 66% | $12,525 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Estradiol (Twice Weekly) | 26 | $1,571 | $60 |
| Estradiol | 17 | $1,139 | $67 |
| Estradiol-Norethindrone Acetat | 11 | $453 | $41 |
2020: 2 drugs
| Estradiol (Once Weekly) | 13 | $653 | $50 |
| Omeprazole | 12 | $87 | $7 |
2019: 5 drugs
| Estradiol | 29 | $1,227 | $42 |
| Omeprazole | 12 | $136 | $11 |
| Amlodipine Besylate | 16 | $105 | $7 |
| Potassium Chloride | 11 | $102 | $9 |
| Citalopram Hbr | 12 | $101 | $8 |
2018: 1 drug
| Estradiol | 39 | $1,747 | $45 |
2017: 3 drugs
| Tranexamic Acid | 12 | $1,322 | $110 |
| Estradiol | 27 | $1,068 | $40 |
| Estradiol-Norethindrone Acetat | 12 | $1,018 | $85 |
2016: 3 drugs
| Vagifem | 13 | $2,227 | $171 |
| Estradiol-Norethindrone Acetat | 13 | $1,097 | $84 |
| Estradiol | 13 | $405 | $31 |
2015: 3 drugs
| Raloxifene | 16 | $3,133 | $196 |
| Estradiol-Norethindrone Acetat | 12 | $985 | $82 |
| Estradiol | 14 | $534 | $38 |
2014: 4 drugs
| Raloxifene | 11 | $2,182 | $198 |
| Vagifem | 13 | $1,289 | $99 |
| Vivelle-Dot | 13 | $1,098 | $84 |
| Estradiol | 24 | $1,097 | $46 |
2013: 3 drugs
| Vagifem | 22 | $2,362 | $107 |
| Estradiol | 31 | $1,039 | $34 |
| Vivelle-Dot | 14 | $1,023 | $73 |
Money from drug and device companies
$252 in 2024
| 2024 | 9 | 14 | None | $252 |
| 2023 | 11 | 20 | None | $401 |
| 2022 | 12 | 34 | None | $760 |
| 2021 | 13 | 34 | None | $453 |
| 2020 | 10 | 19 | None | $289 |
| 2019 | 17 | 25 | None | $372 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Aspira Women's Health | Ova1 | $45 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Mirena | $43 | 2 payments
|
| CooperSurgical | Paragard T 380a | $35 | 2 payments
|
| Astellas Pharma US | Veozah | $35 | 2 payments
|
| Biogen | None | $31 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $19 | 1 payment
|
See all 14 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2024-10-01 | Mirena | $25 |
| Bayer Healthcare Pharmaceuticals | Meals · 2024-04-30 | Mirena | $18 |
| Abbvie | Meals · 2024-03-27 | Liletta | $14 |
| Astellas Pharma US | Meals · 2024-03-25 | Veozah | $18 |
| Exact Sciences | Meals · 2024-03-20 | Cologuard Collection Kit | $19 |
| CooperSurgical | Meals · 2024-03-19 | Paragard T 380a | $21 |
| Shield Therapeutics | Meals · 2024-03-13 | Accrufer | $18 |
| Biogen | Meals · 2024-03-12 | None | $15 |
| Aspira Women's Health | Meals · 2024-03-12 | Ova1 | $30 |
| Organon | Meals · 2024-02-27 | Nexplanon | $13 |
| CooperSurgical | Meals · 2024-02-21 | Summit Doppler | $14 |
| Biogen | Meals · 2024-01-31 | None | $15 |
| Aspira Women's Health | Meals · 2024-01-31 | Ova1 | $15 |
| Astellas Pharma US | Meals · 2024-01-22 | Veozah | $17 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $401
| Aspira Women's Health | Ova1 | $94 | 2 payments
|
| Astellas Pharma US | Veozah | $55 | 3 payments
|
| AbbVie | Ubrelvy | $55 | 3 payments
|
| Organon | Nexplanon | $50 | 3 payments
|
| Exact Sciences | Cologuard Collection Kit | $36 | 2 payments
|
| Pfizer | Abrysvo | $36 | 2 payments
|
| Exeltis USA | Slynd | $19 | 1 payment
|
| CooperSurgical | Mara Console | $15 | 1 payment
|
| Medtronic | Truclear | $14 | 1 payment
|
| Millicent US | Femring | $13 | 1 payment
|
| Avion Pharmaceuticals | Balcoltra | $13 | 1 payment
|
2022: $760
| Aspira Women's Health | Ova1 | $190 | 2 payments
|
| Abbvie | Lo Loestrin Fe | $153 | 14 payments
|
| Astellas Pharma US | Myrbetriq | $99 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $79 | 4 payments
|
| Channel Medsystems | None | $62 | 1 payment
|
| Organon | Nexplanon | $60 | 4 payments
|
| Scynexis | None | $37 | 2 payments
|
| Millicent US | Femring | $20 | 1 payment
|
| Daiichi Sankyo | Injectafer | $19 | 1 payment
|
| Merck Sharp & Dohme | Gardasil 9 | $15 | 1 payment
|
| Exeltis USA | Slynd | $15 | 1 payment
|
| Olympus America | None | $12 | 1 payment
|
2021: $453
| AbbVie | Lo Loestrin Fe | $181 | 16 payments
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $56 | 3 payments
|
| Daiichi Sankyo | Injectafer | $44 | 2 payments
|
| Organon | Nexplanon | $28 | 2 payments
|
| Mylan Pharmaceuticals | Xulane | $26 | 2 payments
|
| Avion Pharmaceuticals | Balcoltra | $24 | 2 payments
|
| Agile Therapeutics | Twirla | $16 | 1 payment
|
| Becton Dickinson and | Bd Surepath | $15 | 1 payment
|
| Mayne Pharma | None | $14 | 1 payment
|
| Exeltis USA | Slynd | $14 | 1 payment
|
| Evofem Biosciences | Phexxi | $13 | 1 payment
|
| Myovant Sciences | Myfembree | $12 | 1 payment
|
| Pfizer | Premarin | $12 | 1 payment
|
2020: $289
| Avion Pharmaceuticals | Balcoltra | $76 | 6 payments
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $55 | 3 payments
|
| CooperSurgical | Endosee | $34 | 2 payments
|
| Merck Sharp & Dohme | Nexplanon | $28 | 2 payments
|
| Becton Dickinson and | Bd Surepath | $23 | 1 payment
|
| AbbVie | Lo Loestrin Fe | $22 | 1 payment
|
| Exeltis USA | Slynd | $15 | 1 payment
|
| Seqirus USA | Flucelvax Quadrivalent (Multi-Dose Vial) | $13 | 1 payment
|
| Mylan Pharmaceuticals | Xulane | $11 | 1 payment
|
| Vertical Pharmaceuticals | Divigel | $11 | 1 payment
|
2019: $372
| CooperSurgical | Gyn Office Instrumental | $49 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $33 | 2 payments
|
| AbbVie | Orilissa | $29 | 2 payments
|
| Duchesnay USA | Osphena | $29 | 2 payments
|
| Merck Sharp & Dohme | Nexplanon | $27 | 2 payments
|
| Avion Pharmaceuticals | Prenate Mini | $27 | 2 payments
|
| Allergan | Lo Loestrin Fe | $25 | 2 payments
|
| Ethicon US | Enseal X1 5mm | $21 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $19 | 1 payment
|
| Daiichi Sankyo | Injectafer | $18 | 1 payment
|
| Endo Pharmaceuticals | Nascobal | $15 | 1 payment
|
| Amgen | Prolia | $14 | 1 payment
|
| Exeltis USA | Slynd | $14 | 1 payment
|
| Vertical Pharmaceuticals | Divigel | $13 | 1 payment
|
| AMAG Pharmaceuticals | Makena | $13 | 1 payment
|
| Mylan Pharmaceuticals | Xulane | $13 | 1 payment
|
| Sanofi Pasteur | Fluzone Quadrivalent | $13 | 1 payment
|
Professional record
- NPI
- 1306836143
- Licence
- TN 19648Tennessee 19648: Expired
More record details
- Sole proprietor
- No
- Medicaid ID
- TN 3052464
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 1304 Duncanwood Ct, Nashville, TN, 37204
- NPI first listed
- 2005-10-24
- NPI last updated
- 2024-05-30
- NPI record certified
- 2024-05-30
This is when the NPI record was last certified, not a medical board exam.